Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05476640
Other study ID # shercru-20220003
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date August 5, 2022
Est. completion date December 31, 2025

Study information

Verified date July 2022
Source Shanghai Children's Hospital
Contact Lin Zou
Phone 18623121280
Email zoulin@shchildren.com.cn
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The project will carry out the genetic testing of 10000 neonates. The aim of the project is to assess the application of targeted sequencing technology in the screening of neonatal diseases.


Description:

Neonatal screening (NBS) is the last step of birth defects prevention. Currently, biochemical and mass spectrometry are commonly used for NBS, but there are limited diseases and certain false positive/negative. High-throughput sequencing (NGS) has been widely used in prenatal diagnosis, tumor-targeted biomarkers detection and pathogen detection. Although the application of NGS in new screening has a broad prospect and many countries around the world have begun to explore it, there are still challenges in the selection of screening diseases, gene clinical phenotypes, genetic counseling and clinical pathway. Since 2019, our team began to explore the appllication of NGS technologies in the clinical application of tertiary prevention, combined with Clinva, HGMD, OMIM database, on the basis of screening specific disease-causing genes and mutation sites as the target, A NGS panel for Newborns in China (NeoExome) was designed, covering 542 single-gene diseases with 601 genes. The rationality and validity of the NGS panel was preliminarily verified in 3423 neonatal blood samples collected from 5 new screening centers in China. In order to further optimize the gene screening spectrum of neonatal diseases in the Chinese population, evaluate the efficacy of targeted sequencing technology in the screening and diagnosis of neonatal diseases, standardize the clinical pathway, and lay a foundation for the formulation of China's new screening NGS guidelines, the investigators further optimized the targeted sequencing package (NeoexOME-V2) on the basis of the first phase. 491 genes covering 485 single-gene genetic diseases were designed to launch the "Budding Action". The project plans to collect 10000 samples nationwide and carry out the multi-center clinical research on the application of targeted sequencing technology in the screening of neonatal diseases.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 10000
Est. completion date December 31, 2025
Est. primary completion date August 31, 2025
Accepts healthy volunteers
Gender All
Age group 1 Day to 28 Days
Eligibility Inclusion Criteria: - -- Subjects: all newborns (from birth to 28 days); - -- After fully understanding the program, the guardian signs the informed consent and agrees to participate in the program. Exclusion Criteria: - Other similar clinical research projects are under way for the examined neonates; - Neonates have received transfusion of allogeneic blood products; - Newborns whose guardians explicitly refuse to participate in the program after receiving the mission. Elimination criteria - Samples that are not properly collected or stored for testing; - Samples with non-standard data records; - Samples without clinical follow-up results; - The project recalls newborns who are required to withdraw by their guardians during the follow-up.

Study Design


Related Conditions & MeSH terms


Intervention

Genetic:
NGS
In the Nation multicenter screening cohort, NGS testing was performed on the basis of conventional NBS to study the relationship between gene variation and disease occurrence;

Locations

Country Name City State
n/a

Sponsors (7)

Lead Sponsor Collaborator
Shanghai Children's Hospital Children's Hospital of Chongqing Medical University, Huzhou Maternity and Child Health Care Hospital, Inner Mongolia Maternal and Child Health Care Hospital, Northwest Women's and Children's Hospital, Xuzhou maternal and Child Health Care Hospital, Zunyi Maternal and Child Health Care Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Disease incidence among NGS positive participants Newborn was followed up for 3 years after birth, and the follow-up results were compared to evaluate and study the relationship between gene variation and disease occurrence 3 years
Secondary The consistency of test results of NGS and conventional NBS Conventional NBS was used as the standard to study the application potential of targeted sequencing technology in neonatal screening and evaluate its consistency 1 year
See also
  Status Clinical Trial Phase
Completed NCT01687634 - Home Visiting for Low Income, Pregnant Women N/A
Completed NCT02584166 - Intervention of Psychological and Ethical Professionals of Human Science in Obstetrical Morbidity and Mortality Conferences (OPERA) N/A
Recruiting NCT04598061 - IV Dexmedetomidine as Spinal Anesthesia Adjuvant in Infants
Recruiting NCT04410250 - Effect of Oral Hygienization in Newborn on Candida Spp Colonization N/A
Recruiting NCT05705258 - A Study to Collect Data on the Use of Eylea in Babies Born Too Early Who Have a Condition of the Eye Where Blood Vessels Grow Abnormally in the Retina (Retinopathy of Prematurity)
Recruiting NCT02785679 - The Influence of Early and Continuous Exposure of Infants to Cow's Milk Formula on the Prevention of Milk Allergy N/A
Recruiting NCT06350071 - Effect of Kangaroo Care and Swaddling Methods on Pain Level and Crying Time During Heel Blood Collection N/A
Terminated NCT03142984 - UK Baby Study Using a Baby Wash and Lotion Regimen N/A
Completed NCT06387888 - The Effect of Mother's Voice on the Levels of Pain and Comfort in Newborns N/A
Completed NCT02827019 - Newborn in Helathy Birthroom: Assessment of Pratical Home and Mother Lived
Recruiting NCT04984967 - Interest of Peripheral Venous Catheter Insertion Using a Micro-guide in Neonatology N/A
Completed NCT04492579 - Newborns Supplemented With Gentle-UHT Donor Milk N/A
Completed NCT03637894 - Immunity Modification of Full Term Infants According to the Type of Feeding and Mode of Delivery N/A